Document:

Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This Securities
Purchase Agreement (this “Agreement”) is made as of January 7, 2022 (the “Effective Date”),
by and between Bristol-Myers Squibb Company, a Delaware corporation (the “Investor”),
and Century Therapeutics, Inc., a Delaware corporation (the “Company”).

 

RECITALS

 

WHEREAS, on the Effective Date, the Company and
the Investor entered into a Research Collaboration and License Agreement (the “Collaboration Agreement”); and

 

WHEREAS, pursuant to the terms and subject to the
conditions set forth in this Agreement, the Company desires to issue and sell to the Investor, and the Investor desires to subscribe for
and purchase from the Company, 2,160,760 shares of common stock, $0.0001 par value per share, of the Company (the “Common Stock”);
and

 

NOW, THEREFORE, in consideration of the following
mutual promises and obligations, and for good and valuable consideration, the adequacy and sufficiency of which are hereby acknowledged,
the Investor and the Company agree as follows:

 

Article
1

Definitions

 

1.1             
Defined Terms. When used in this Agreement, the following terms shall have the respective meanings specified therefor below:

 

“2018 Stock Option and Grant Plan”
shall mean the Company’s 2018 Stock Option and Grant Plan, as amended to date and as the same may be amended and/or restated from
time to time.

 

“2021 Equity Incentive Plan”
shall mean the Company’s 2021 Equity Incentive Plan, as amended to date and as the same may be amended and/or restated from time
to time.

 

“Affiliate” shall mean, with
respect to any Person, another Person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is
under common control with such Person. A Person shall be deemed to control another Person if such Person possesses, directly or indirectly,
the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities,
by contract or otherwise. Without limiting the generality of the foregoing, a Person shall be deemed to control another Person if such
Person owns, directly or indirectly, beneficially or legally, more than fifty percent (50%) of the outstanding voting securities or capital
stock of such other Person, or has other comparable ownership interest with respect to any Person other than a corporation. For the purposes
of this Agreement, in no event shall the Investor or any of its Affiliates be deemed Affiliates of the Company or any of its Affiliates,
nor shall the Company or any of its Affiliates be deemed Affiliates of the Investor or any of its Affiliates.

 

“Agreement” shall have the meaning
set forth in the Preamble.

 

     

     

    

 

“Board” shall mean the Board
of Directors of the Company.

 

“Business Day” shall mean a
day on which banking institutions in New York, New York are open for business, excluding any Saturday or Sunday.

 

“Change of Control” shall mean
the transfer, in one transaction or a series of related transaction, as a result of which any Person or group of Persons, other than the
Company, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of more than 50% of the total voting power
of the voting securities of the Company.

 

“Closing Date” means the third
Business Day following the date on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto,
and all conditions precedent to (i) Investor’s obligations to pay the Aggregate Purchase Price and (ii) the Company’s obligations
to deliver the Purchased Shares in each case, have been satisfied or waived, or such other date as may be agreed between the Investor
and the Company.

 

“Collaboration Agreement” shall
have the meaning set forth in the Preamble.

 

“Company SEC Documents” shall
mean the reports, schedules, forms, statements and other documents (including exhibits and all other information incorporated therein)
required to be filed by it under the Securities Act and the Exchange Act, and any required amendments to any of the foregoing, in each
case filed with the SEC prior to the date hereof (or, in the case of Section 3.11(a) only, filed with the SEC prior to, on, or after the
date hereof).

 

“Exchange Act” shall mean the
Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“GAAP” shall mean generally
accepted accounting principles in the United States.

 

“Governmental Authority” shall
mean any multinational, federal, national, state, provincial, local or other entity, office, commission, bureau, agency, political subdivision,
instrumentality, branch, department, authority, board, court, arbitral or other tribunal exercising executive, judicial, legislative,
police, regulatory, administrative or taxing authority or functions of any nature pertaining to government.

 

“LAS” shall mean the Nasdaq
Notification Form: Listing of Additional Shares.

 

“Law” shall mean any law, statute,
rule, regulation, order, judgment or ordinance having the effect of law of any federal, national, multinational, state, provincial, county,
city or other political subdivision.

 

    -2-

     

    

 

“Material Adverse Effect”
shall mean any change, event or occurrence that, individually or in the aggregate, results in a material adverse effect on the
business, or results of operations, assets or condition of the Company and its subsidiaries taken as a whole, provided, however,
that no change, event, circumstance, occurrence or development resulting from the following shall be deemed (either alone or in
combination) to constitute or shall be taken into account in determining whether there has been a Material Adverse Effect: (a)
changes in conditions in the United States or global economy or capital or financial markets generally, including changes in
interest or exchange rates, (b) changes in general legal, regulatory, political, economic or business conditions or changes in
generally accepted accounting principles in the United States or interpretations thereof, (c) acts of war, sabotage, cyber attack,
military action or terrorism, or any escalation or worsening of any such acts of war, sabotage, cyber attack, military action or
terrorism, (d) earthquakes, hurricanes, floods, pandemics or other natural disasters, (e) the announcement of this Agreement, the
Collaboration Agreement or the transactions contemplated hereby and thereby, (f) any change in the Company’s stock price or
trading volume or any failure to meet internal projections or forecasts or published revenue or earnings projections of industry
analysts (provided that the underlying events giving rise to any such change shall not be excluded, except to the extent any
such event is included in clause (a) through (e) of this definition); (g) any breach, violation or non-performance by the Investor
or any of its Affiliates under the Collaboration Agreement, or (h) any action taken, or failed to be taken, by the Company at the
request or with the consent of the Investor or otherwise in compliance with the terms of this Agreement; provided, however, that the
events excluded in clauses (a), (b), (c) and (d) shall only be excluded to the extent the effects of such events are not
disproportionately adverse on the Company and its subsidiaries as compared to other companies operating in the Company’s
industry.

 

“Person” shall mean any individual,
partnership, joint venture, limited liability company, corporation, firm, trust, association, unincorporated organization, Governmental
Authority or other entity, as well as any syndicate or group that would be deemed to be a Person under Section 13(d)(3) of the Exchange
Act.

 

“Rule 144” shall mean Rule 144
promulgated under the Securities Act.

 

“SEC” shall mean the U.S. Securities
and Exchange Commission.

 

“Securities Act” shall mean
the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Third Party” shall mean any
Person other than the Investor, the Company or any Affiliate of the Investor or the Company.

 

“Transfer Agent” shall mean
the Company’s transfer agent.

 

“Transaction Documents” means
this Agreement, all exhibits and schedules hereto and any other documents or agreements executed in connection with the transactions contemplated
hereunder. For clarity, Transaction Documents shall not include the Collaboration Agreement.

 

Article
2

Purchase and Sale of Common Stock

 

2.1              Purchase
and Sale. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company shall issue and sell
to the Investor, and the Investor shall purchase from the Company, 2,160,760 shares of Common Stock (the “Purchased
Shares”), at a price per share of $23.14, for an aggregate purchase price of Fifty Million Dollars ($50,000,000) (the
 “Aggregate Purchase Price”). The Company shall deliver to Investor the Purchased Shares, and the Company and
Investor shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction (or waiver in
accordance hereof) of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur on the Closing Date at
10:00 a.m. New York time at the offices of Troutman Pepper Hamilton Sanders LLP or such other time, date and location as the parties
shall mutually agree.

 

    -3-

     

    

 

2.2             
Deliveries.

 

(a)              
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to Investor:

 

(i)                
a legal opinion from Troutman Pepper Hamilton Sanders LLP, United States legal counsel to the Company, in form and substance
reasonably acceptable to Investor;

 

(ii)             
a certificate in form and substance reasonably satisfactory to the Investor and duly executed on behalf of the Company by an
authorized executive officer of the Company, certifying that the conditions to Closing set forth in Section 2.3(b) of this Agreement
have been fulfilled;

 

(iii)           
a certificate, executed on behalf of the Company by its Secretary, dated as of the Closing Date, certifying the Board of Directors
of the Company has approved the transactions contemplated by this Agreement and the other Transaction Documents and the issuance of the
Purchased Shares and that they remain in effect, certifying the current versions of the Company’s Second Amended and Restated Certificate
of Incorporation and Amended and Restated Bylaws and certifying as to the signatures and authority of persons signing the Transaction
Documents and related documents on behalf of the Company; and

 

(iv)            
Subject to Section 4.10, the Company shall instruct the Transfer Agent to issue the Purchased Shares in book entry form in
the name of the Investor.

 

(b)             
The Investor shall pay the Aggregate Purchase Price to the Company on the Closing Date by wire transfer of immediately available
United States funds to the Company’s account set forth on Schedule I.

 

2.3             
Closing Conditions. 

 

(a)              
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met (or
waived by Company):

 

(i)                 the
representations and warranties made by the Investor in Article 4 shall be true and correct in all material respects as of the
date when made and as of the Closing Date (unless any such representation or warranty speaks as of a specific date therein, in which
case such representation or warranty shall be true and correct in all material respects as of such date), except for those
representations and warranties that are qualified as to materiality, in which case such representations and warranties shall be true
and correct in all respects as of the date when made and as of the Closing Date (unless any such representation or warranty speaks
as of a specific date therein, in which case such representation or warranty shall be true and correct as of such date);

 

    -4-

     

    

 

(ii)             
all obligations, covenants and agreements of Investor required to be performed at or prior to the Closing Date shall have been
performed in all material respects (or, to the extent obligations, covenants and agreements are qualified by materiality or Material Adverse
Effect, in all respects); and

 

(iii)           
the delivery by Investor of the Aggregate Purchase Price;

 

(b)             
 The obligations of Investor hereunder in connection with the Closing are subject to the following conditions being met (or
waived by Investor):

 

(i)                
The representations and warranties made by the Company in Article 3 hereof shall be true and correct in all material
respects as of the date of this Agreement and as of the Closing Date as though made on and as of such dates, except to the extent such
representations and warranties (i) are already qualified by materiality, “Material Adverse Effect” or words of similar import,
in which case such representations and warranties shall be true and correct as of such dates in all respects or (ii) are specifically
made as of a particular date, in which case such representations and warranties shall be true and correct as of such date;

 

(ii)             
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have
been performed in all material respects (or, to the extent obligations, covenants and agreements are qualified by materiality or Material
Adverse Effect, in all respects);

 

(iii)           
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

 

(iv)            
From and after the Effective Date until the Closing Date, there shall have occurred no event that has caused or would reasonably
be expected to cause a Material Adverse Effect;

 

(v)              
The Purchased Shares shall be duly listed, and admitted and authorized for trading, on the Nasdaq Global Market (“Nasdaq”);
and

 

(vi)            
the sale of the Purchased Shares by the Company to the Investor hereunder shall not be prohibited by any Law.

 

Article
3

Representations and Warranties of the Company

 

The Company hereby represents and warrants of the
date hereof and as of the Closing Date to the Investor as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):

 

3.1             
Organization, Good Standing and Qualification.

 

(a)              
 The Company and each of its subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good
standing (to the extent the concept of good standing is applicable in such jurisdiction) under the laws of the jurisdiction of its incorporation
and organization. The Company and each of its subsidiaries has all requisite corporate power and corporate authority to own, lease and
operate its properties and assets, to carry on its business as now conducted and, in the case of the Company, (i) as proposed to be conducted
as described in the Company SEC Documents, (ii) to enter into the Transaction Documents, (iii) to issue and sell the Purchased Shares
and (iv) to carry out the other transactions contemplated by the Transaction Documents.

 

    -5-

     

    

 

(b)             
The Company is qualified to transact business and is in good standing in each jurisdiction in which the character of the properties
owned, leased or operated by the Company or the nature of the business conducted by the Company makes such qualification necessary, except
where the failure to be so qualified or in good standing would not reasonably be likely to have a Material Adverse Effect.

 

3.2             
Capitalization and Voting Rights.

 

(a)              
The authorized capital of the Company consists of: (i) 300,000,000 shares of Common Stock, of which (A) 56,555,073
shares are issued and outstanding, (B) 618,834 shares are issuable upon the exercise of outstanding stock options or restricted stock
awards under the 2021 Equity Incentive Plan; (C) 5,021,877 shares are reserved for future issuance pursuant to the 2021 Equity Incentive
Plan, (D) 5,545,074 shares are issuable upon the exercise of outstanding stock options or restricted stock awards under the 2018 Stock
Option and Grant Plan, (E) no shares are reserved for future issuance under the 2018 Stock Option and Grant Plan, and (F) 16,112 shares
are issuable upon the exercise of outstanding warrants to purchase Common Stock and (ii) 10,000,000 shares of preferred stock, $0.0001
par value per share (the “Preferred Stock”), of which no shares are issued and outstanding. All of the issued and outstanding
shares of Common Stock have been duly authorized and validly issued and are fully paid and non-assessable, were issued in compliance with
applicable securities Laws. None of the outstanding shares of Common Stock were issued in violation of any preemptive rights, rights of
first refusal or other similar rights to subscribe for or purchase securities of the Company.

 

(b)             
There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase,
or equity or debt securities convertible into or exchangeable or exercisable for, any share capital of the Company other than those described
in the Company SEC Documents or as otherwise set forth in Section 3.2(a) above.

 

(c)              
Except as disclosed in the Company SEC Documents, no Person has any right to cause the Company to effect the registration under
the Securities Act of any securities of the Company, except for such rights as have been duly waived or expired.

 

(d)             
The Company’s Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has
taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock
under the Exchange Act nor has the Company received any notification that the SEC is contemplating terminating such registration.

 

    -6-

     

    

 

(e)              
 Other than as described in the Company SEC Documents, no stop order or suspension of trading of the Company’s Common
Stock has been imposed or to the Company’s knowledge, threatened by the Nasdaq Stock Market, the SEC or any other Governmental Authority
and remains in effect.

 

3.3             
Subsidiaries. Except as otherwise disclosed in the Company SEC Documents, the Company does not own or control, directly or
indirectly, any corporation, association or other entity.

 

3.4             
Authorization. This Agreement has been duly authorized, executed and delivered by the Company and, assuming the due execution
and delivery of this Agreement by the Investor, constitutes valid and legally binding obligations of the Company, enforceable against
the Company in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting creditors’ rights generally or by equitable principles relating to enforceability.

 

3.5             
No Defaults. The Company is not (a) in violation of its Second Amended and Restated Certificate of Incorporation or Amended
and Restated Bylaws or similar organizational documents; (b) other than as described in the Company SEC Documents, in default (nor,
with the giving of notice or lapse of time, would it be in default) under any indenture, loan, credit agreement, note, lease, license
agreement, contract, franchise or other instrument (including, without limitation, any pledge agreement, security agreement, mortgage
or other instrument or agreement evidencing, guaranteeing, securing or relating to indebtedness) to which the Company is a party or by
which it may be bound, or to which any of its properties or assets are subject (an “Existing Instrument”); or (c) other
than as described in the Company SEC Documents, in violation of any law or statute or any judgment, order, rule or regulation of any court
or arbitrator or governmental or regulatory authority having jurisdiction over the Company or any of its subsidiaries, except, in the
case of clauses (b) and (c), for any such default or violation that would not, individually or in the aggregate, have a Material Adverse
Effect.

 

3.6             
No Conflicts. The execution, delivery and performance of this Agreement, the issuance and sale of the Purchased Shares and
the consummation of the transactions contemplated by this Agreement (a) have been duly authorized by all necessary corporate action and
will not result in any violation of the Second Amended and Restated Certificate of Incorporation or Amended and Restated Bylaws of the
Company, (b) will not conflict with or constitute a breach of, or default under, or result in the creation or imposition of any lien,
charge or encumbrance upon any property or assets of the Company pursuant to, or require the consent of any other party to, any Existing
Instrument and (c) will not result in any violation of any law, administrative regulation or administrative or court decree applicable
to the Company, except, in the case of clauses (b) and (c), for any such conflict, breach, violation or default that would not, individually
or in the aggregate, have a Material Adverse Effect.

 

3.7              No
Governmental Authority or Third Party Consents. No consent, approval, authorization or other order of, or registration or filing
with, any court or other governmental or regulatory authority or agency is required for the execution, delivery and performance by
the Company of this Agreement or the issuance and sale of the Purchased Shares, except (a) such filings as may be required to be
made with the SEC or with any state blue sky or securities regulatory authority, which filings shall be made in a timely manner in
accordance with all applicable Laws, and (b) with respect to the Purchased Shares, the filing with the Nasdaq Stock Market of, and
the absence of unresolved issues with respect to, an LAS and, if required, a Nasdaq Shares Outstanding Change Form.

 

    -7-

     

    

 

3.8             
Valid Issuance of the Purchased Shares. The Purchased Shares have been duly authorized for issuance and sale pursuant to this
Agreement and, when issued and delivered by the Company against payment therefor, will be validly issued, fully paid and non-assessable,
and the issuance and sale of the Purchased Shares is not subject to any preemptive rights, rights of first refusal or other similar rights
to subscribe for or purchase Common Stock.

 

3.9             
Litigation. Except as disclosed in the Company SEC Documents, there is (i) no action, suit, proceeding or (with respect to
which the Company or any of its subsidiaries has received notice) investigation pending, or, to the Company’s knowledge, threatened,
against the Company or any of its subsidiaries and (ii) no action, suit, proceeding or investigation which the Company or any of its subsidiaries
intends to initiate, in either case which has had or is reasonably likely to have a Material Adverse Effect. No labor dispute exists or,
to the knowledge of the Company, is threatened, against the Company or any of its subsidiaries which has had or is reasonably likely to
have a Material Adverse Effect.

 

3.10         
Regulatory Permits. The Company and each of the subsidiaries possess all certificates, authorizations and permits issued by
the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described
in the Company SEC Documents, except where the failure to possess such permits would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect (“Material Permits)”, and neither the Company nor any Subsidiary has
received any notice of proceedings relating to the revocation or modification in any material respect of any Material Permit.

 

3.11         
The Company SEC Documents; Financial Statements; Nasdaq Stock Market.

 

(a)              
As of their respective filing dates each of the Company SEC Documents complied in all material respects with the requirements
of the Securities Act, the Exchange Act, and the rules and regulations of the SEC promulgated thereunder applicable to such Company SEC
Documents, and no Company SEC Documents when filed, declared effective or mailed, as applicable, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light
of the circumstances under which they were made, not misleading. There are no outstanding or unresolved comments in comment letters received
from the SEC or its staff.

 

(b)              The
financial statements of the Company included in its Registration Statement on Form S-1, dated May 28, 2021, as amended, and in each
of its quarterly reports on Form 10-Q for the quarterly periods ended June 30, and September 30 of the current fiscal year filed
with the SEC as of the date of this Agreement present fairly the financial position of the Company and its consolidated subsidiaries
as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such
financial statements have been prepared in conformity with GAAP applied on a consistent basis throughout the periods covered
thereby, except as otherwise disclosed therein and, in the case of unaudited, interim financial statements, subject to normal
year-end audit adjustments and the exclusion of certain footnotes, and any supporting schedules included in the Company SEC
Documents present fairly the information required to be stated therein.

 

    -8-

     

    

 

(c)              
The Common Stock is listed on the Nasdaq Stock Market, and the Company has taken no action designed to, or which is likely
to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the
Nasdaq Stock Market. Other than as described in the Company SEC Documents, the Company has not received any notification that, and has
no knowledge that, the SEC or the Nasdaq Stock Market is contemplating terminating such listing or registration.

 

(d)             
Other than as described in the Company SEC Documents, since the end of the Company’s most recent audited fiscal year,
there have been no significant deficiencies or material weakness in the Company’s internal control over financial reporting (whether
or not remediated) and no change in the Company’s internal control over financial reporting that has materially affected, or is
reasonably likely to materially affect, the Company’s internal control over financial reporting. Other than as described in the
Company SEC Documents, the Company is not aware of any change in its internal control over financial reporting that has occurred during
its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal
control over financial reporting.

 

(e)              
The Company maintains disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) that (i) are designed
to ensure that material information relating to the Company, is made known to the Company’s principal executive officer and its
principal financial officer by others within those entities, particularly during the periods in which the periodic reports required under
the 1934 Act are being prepared; (ii) have been evaluated by management of the Company for effectiveness as of the end of the Company’s
most recent fiscal quarter; and (iii) are effective in all material respects at the reasonable assurance level to perform the functions
for which they were established The Company has conducted evaluations of the effectiveness of its disclosure controls as required by Rule
13a-15 of the Exchange Act.

 

(f)               
Other than as described in the Company SEC Documents, there is and has been no material failure on the part of the Company
or, to the knowledge of the Company, any of the Company’s directors or officers, in their capacities as such, to comply with any
applicable provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith, including Section
402 related to loans and Sections 302 and 906 related to certifications.

 

3.12          Absence
of Certain Changes. Since September 30, 2021 and other than as described in the Company SEC Documents, (a) there has not
occurred any event that has caused or would reasonably be expected to cause a Material Adverse Effect on the Company and its
subsidiaries, taken as a whole; (b) the Company has not entered into any transactions not in the ordinary course of business that
are material, individually or in the aggregate, to the Company; and (c) there has not been any material decrease in the share
capital or any material increase in any short-term or long-term indebtedness of the Company and there has been no dividend or
distribution of any kind declared, paid or made by the Company or any repurchase or redemption by the Company of any class of share
capital.

 

    -9-

     

    

 

3.13         
Offering. Subject to the accuracy of the Investor’s representations set forth in Article 4, the offer, sale and issuance
of the Purchased Shares to be issued in conformity with the terms of this Agreement constitute transactions which are exempt from the
registration requirements of the Securities Act and from all applicable state registration or qualification requirements. Neither the
Company nor any Person acting on its behalf will take any action that would cause the loss of such exemption.

 

3.14         
No Integration. The Company has not, directly or through any agent, sold, offered for sale, solicited offers to buy or otherwise
negotiated in respect of, any security (as defined in the Securities Act), that is or will be integrated with the sale of the Purchased
Shares in a manner that would require registration of the Purchased Shares under the Securities Act.

 

3.15         
Intellectual Property. The representations and warranties of the Company set forth in Section 10.2 of the Collaboration Agreement
are incorporated into this Agreement, except that no representation or warranty set forth in Section 10.2 related to future events or
the Company’s future actions is incorporated into this Agreement.

 

3.16         
U.S. Real Property Holding Corporation. The Company is not a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended.

 

3.17         
Bank Holding Company Act. Neither the Company nor any of its subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended and to regulation by the Board of Governors of the Federal Reserve System.

 

3.18         
Money Laundering. The operations of the Company and its subsidiaries are and have been conducted at all times in material compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering
Laws”), and no action or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

3.19         
Brokers’ or Finders’ Fees. There is no broker, finder or other party that is entitled to receive from the Company
any brokerage or finder’s fee or other fee or commission as a result of any transactions contemplated by this Agreement.

 

3.20         
Investment Company. The Company is not and, immediately after giving effect to the offering and sale of the Purchased Shares
and the application of the proceeds thereof, will not be required to register as an “investment company” under the Investment
Company Act of 1940, as amended, and the rules and regulations of the SEC thereunder.

 

    -10-

     

    

 

3.21         
 No General Solicitation. Neither the Company nor any person acting on behalf of the Company has offered or sold any of the
Purchased Shares by any form of general solicitation or general advertising. The Company has offered the Purchased Shares for sale only
to the Investor.

 

3.22         
Regulation M Compliance. The Company has not taken, directly or indirectly, any action designed to or that would reasonably
be expected to cause or result in stabilization or manipulation of the price of the Common Stock to facilitate the sale or resale of the
Purchased Shares.

 

Article
4

Representations and Warranties of the Investor

 

The Investor hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which
case they shall be accurate as of such date):

 

4.1             
Organization; Good Standing. The Investor is a corporation duly organized, validly existing and in good standing under the
laws of the State of Delaware. The Investor has all requisite corporate power and corporate authority to enter into this Agreement, to
purchase the Purchased Shares and to perform its obligations under and to carry out the other transactions contemplated by this Agreement.

 

4.2             
Authorization.

 

(a)              
The Investor has full right, power and authority to execute and deliver this Agreement and to perform its obligations hereunder;
and all action required to be taken for the due and proper authorization, execution and delivery by it of this Agreement and the consummation
by it of the transactions contemplated hereby has been duly and validly taken.

 

(b)             
This Agreement has been duly executed and delivered by the Investor and, assuming the due execution and delivery of this Agreement
by the Company, constitutes valid and legally binding obligations of the Investor, enforceable against the Investor in accordance with
its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
creditors’ rights generally or by equitable principles relating to enforceability.

 

4.3              No
Conflicts. The execution, delivery and performance of this Agreement, the subscription for and purchase of the Purchased Shares
and the consummation of the transactions contemplated by this Agreement will not (a) conflict with or result in a breach or
violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien,
charge or encumbrance upon any property or assets of the Investor pursuant to, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument to which the Investor is a party, by which the Investor is bound or to which any of the
property or assets of the Investor is subject, (b) result in any violation of the provisions of the certificate of incorporation or
by-laws or similar organizational documents of the Investor or (c) result in the violation of any law or statute or any judgment,
order, rule or regulation of any court or arbitrator or governmental or regulatory authority having jurisdiction over the Investor
or any of its subsidiaries, except, in the case of clauses (a) and (c), for any such conflict, breach, violation or default that
would not, individually or in the aggregate, have a material adverse effect on the Investor’s ability to perform its
obligations or consummate the transactions contemplated hereby in accordance with the terms of this Agreement.

 

    -11-

     

    

 

4.4             
No Governmental Authority or Third Party Consents. No consent, approval, authorization, order, license, registration or qualification
of or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by
the Investor of this Agreement or with the subscription for and purchase of the Purchased Shares.

 

4.5             
Purchase Entirely for Own Account. The Investor is subscribing for the Purchased Shares as principal and acknowledges that
the Purchased Shares shall be acquired for investment for the Investor’s own account, not as a nominee or agent, and not with a
view to the resale or distribution of any part thereof, and the Investor has no present intention of selling, granting any participation
or otherwise distributing the Purchased Shares. The Investor can bear the economic risk of an investment in the Purchased Shares indefinitely
and a total loss with respect to such investment. The Investor does not have any contract, undertaking, agreement, arrangement or understanding
with any Person to sell, transfer or grant participation to a Person any of the Purchased Shares.

 

4.6             
Disclosure of Information. The Investor has received or has had reasonable access to all the information from the Company and
its management that the Investor considers necessary or appropriate for deciding whether to purchase the Purchased Shares hereunder. The
Investor further represents that it has had an opportunity to ask questions and receive answers from the Company regarding the Company,
its financial condition, results of operations and prospects and the terms and conditions of the offering of the Purchased Shares sufficient
to enable it to evaluate its investment. The Investor has sought such accounting, legal and tax advice as it has considered necessary
to make an informed decision with respect to its acquisition of the Purchased Shares.

 

4.7             
Investment Experience and Accredited Investor Status. The Investor is an “accredited investor” (as defined in Regulation
D under the Securities Act). The Investor has such knowledge and experience in financial or business matters that it is capable of evaluating
the merits and risks of the investment in the Purchased Shares to be purchased hereunder.

 

4.8             
Acquiring Person. Neither the Investor nor any of its Affiliates beneficially owns (in each case, as determined pursuant to
Rule 13d-3 under the Exchange Act without regard for the number of days in which a Person has the right to acquire such beneficial ownership,
and without regard to the Investor’s rights under this Agreement), any securities of the Company.

 

4.9              Restricted
Securities. The Investor understands that the Purchased Shares, when issued, shall be “restricted securities” under
U.S. federal securities Laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering
and that under such Laws the Purchased Shares may be resold without registration under the Securities Act only in certain limited
circumstances. The Investor represents that it is familiar with Rule 144, as presently in effect.

 

    -12-

     

    

 

4.10         
Legends. The Investor understands that any certificates representing the Purchased Shares shall bear the following legends:

 

(a)              
“These securities have not been registered under the Securities Act of 1933. They may not be sold, offered for sale,
pledged or hypothecated in the absence of a registration statement in effect with respect to the securities under the Securities Act or
an opinion of counsel (which counsel shall be reasonably satisfactory to the Company) that such registration is not required or unless
sold pursuant to Rule 144 of the Securities Act.”;

 

(b)             
“These securities are subject to transfer restrictions set forth in a Securities Purchase Agreement by and between Century
Therapeutics, Inc. and Bristol-Myers Squibb Company. Unless permitted by the Company, the holder of these securities is not permitted
to trade these securities until January 7, 2023”; and

 

(c)              
any legend required by applicable state securities Laws.

 

4.11         
Company SEC Documents. The Investor has reviewed the Company SEC Documents.

 

Article
5

Covenants and Agreements

 

5.1             
Market Listing. The Company shall use all commercially reasonable efforts to effect the listing of the Purchased Shares on
the Nasdaq Stock Market, including submitting the LAS to the Nasdaq Stock Market.

 

5.2              Lock-Up
Agreement. Until the first anniversary of the Effective Date (the “Lock-Up Period”), without the prior
approval of the Company, the Investor shall not, and shall cause its controlled Affiliates not to (a) offer, pledge, sell, contract
to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for
the sale or, or otherwise dispose of or transfer any of the Purchased Shares (together with (i) any shares of Common Stock issued in
respect thereof as a result of any stock split, stock dividend, share exchange, merger, consolidation, or similar recapitalization
and (ii) any shares of Common Stock issued as (or issuable upon the exercise of any warrant or other securities that is issued as) a
dividend or other distribution with respect to, or in exchange or in replacement of, the Purchased Shares (the “Lock-Up
Securities”)), including, without limitation, any “short sale” or similar arrangement, or (b) enter into any
swap or any other agreement or any transaction that transfer, in whole or in part, directly or indirectly, the economic consequence
of ownership of the Purchased Shares, whether any such swap or transaction is to be settled by deliver of securities, in cash or
otherwise; provided, however, that the foregoing shall not (i) prohibit the Investor or its Affiliates from transferring Lock-Up
Securities to an Affiliate of the Issuer if such transferee Affiliate executes an agreement with the Company to be bound by the
restrictions set forth in this Section 5.2 and Section 5.3; (ii) prohibit the Investor or its Affiliates from selling or otherwise
disposing of or transferring Lock-Up Securities into a tender offer by a Third Party or an issuer tender offer by the Company; and
(iii) restrict any sale or other disposal or transfer of Common Stock which are not Lock-Up Securities held by an executive officer
or director of the Investor for his or her personal account, or that may occur (or be deemed to occur) in connection with a Change
of Control of the Investor (replacing references to “the Company” with “the Investor” in the definition of
 “Change of Control”). Transfers, sales and other disposals referred to in clauses (i) through (iii) are referred to in
this Agreement as “Excluded Transfers”.

 

    -13-

     

    

 

5.3             
Sale Volume Limitation. Subject to the restrictions set forth in Section 5.2, the Investor agrees that, except for any
Excluded Transfer, it shall not, and shall cause its controlled Affiliates not to, dispose of any shares of Common Stock at any time after
the expiration of the Lock-Up Period, except: (i) in a manner consistent with Rule 144 under the Securities Act, (ii) pursuant to privately
negotiated sales in transactions exempt from the registration requirements under the Securities Act except to any Person who after such
acquisition would beneficially own more than five percent (5%) of the Company’s Common Stock then outstanding and to knowledge of
the Investor, after reasonable inquiry, would report its ownership position on Schedule 13D (or successor form), or (iii) in any transaction
approved in writing by the Company.

 

5.4             
Standstill. Without the prior approval of the Company, during the Research Term (as defined in the Collaboration Agreement)
and for one (1) year thereafter, the Investor agrees that it will not, and will cause its Affiliates to not, directly or indirectly:

 

(a)              
purchase, offer to purchase, or agree to purchase or otherwise acquire beneficial ownership (as determined in accordance with
Rule 13d-3 and Rule 13d-5 under the Exchange Act) of any Common Stock, or any securities convertible or exchangeable into Common Stock,
excluding the Lock-Up Securities;

 

(b)             
make, or participate in, any solicitation of proxies to vote any voting securities of the Company or any of its subsidiaries,
or propose to change or control the management or board of directors of the Company by use of any public communication to holders of securities
intended for such purpose; provided, however, that nothing in this Section 5.4 shall limit the Investor’s ability to vote or
transfer (subject to Sections 5.2 and 5.3) its Common Stock;

 

(c)              
make a public proposal for a Change of Control, including a merger, consolidation or other business combination transaction
or tender offer related thereto, or the purchase of all or substantially all of the assets of the Company and its subsidiaries; or

 

(d)             
knowingly encourage, accept, or support a tender or exchange offer proposal by any Person other than the Investor, the consummation
of which would result in a Change of Control.

 

    -14-

     

    

 

Notwithstanding anything to the contrary
contained in this Agreement, (i) if at any time (A) a Third Party enters into an agreement with the Company contemplating a Change
of Control, including a merger, consolidation or other business combination transaction or tender offer related thereto, or the
purchase of all or substantially all of the assets of the Company and its subsidiaries, or publicly announces its intention to do
so, or (B) a Third Party commences, or publicly announces an intention to commence, a tender, exchange, or offer that, if
consummated, would result in a Change of Control, then the foregoing restrictions set forth in this Section 5.4 shall terminate and
be of no further force or effect; (ii) the Investor shall not be precluded from making any confidential offers or proposals to the
Board in a manner reasonably believed not to require the Company to make a public announcement of such offer or proposal; provided
that the Investor shall not publicly disclose any such offers or proposals unless required by applicable law or the rules or
regulations of the SEC or any securities exchange; (iii) the Investor and its Affiliates shall not be precluded from (A) acquiring
securities of, or from entering into any merger or other business combination with, another Person which beneficially owns
securities of the Company; provided, that the purpose of entering into such transaction is not to circumvent the terms in
this Section 5.4; or (B) owning or acquiring interests in mutual funds or similar entities that own capital stock of the Company;
and (iv) nothing in this Agreement shall prohibit passive investments by pension or employee benefit plans of the Investor.

 

5.5             
Legend Removal.

 

(a)              
Certificates evidencing the Purchased Shares shall not contain the legend set forth in 4.10(a): (i) following any sale of such
Purchased Shares pursuant to Rule 144; (ii) if such Purchased Shares are eligible for sale under Rule 144 without the requirement for
the Company to be in compliance with the current public information required under Rule 144 as to such Purchased Shares and without volume
or manner-of-sale restrictions under Rule 144; or (iii) if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the SEC).

 

(b)             
The Company agrees that at such time as any legend set forth in Section 4.10 is no longer required under this Section
5.5, the Company will, no later than three (3) Business Days following the delivery by the Investor to the Company, or notice by the Investor
to the Company of delivery by the Investor to the Transfer Agent of a certificate representing Purchased Shares issued with such legend
(together, in the case of Section 5.5(a)(i), with any legal opinion required by the Transfer Agent), deliver or cause to be delivered
to the Investor a certificate representing such Purchased Shares that is free from such legend, or, in the event that such shares are
uncertificated, remove any such legend in the Company’s share records. The Company further agrees that it shall, upon written request
by the Investor, cause its counsel to issue to the Transfer Agent, if required by the Transfer Agent, a "blanket" legal opinion
or other letter to allow sales without restriction in the cases of Section 5.5(a)(ii) and (iii) and provide all other opinions of counsel
as may reasonably be required by the Transfer Agent in connection with the removal of legends pursuant to Section 5.5(a)(ii) and (iii).
Any fees (with respect to the Transfer Agent or, Company counsel or otherwise) associated with the issuance of the opinion or the removal
of the legends as contemplated by the preceding sentence shall be borne by the Company. The Company may not make any notation on its records
or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in Section 4.10.

 

    -15-

     

    

 

Article
6

Miscellaneous

 

6.1             
 Governing Law; Dispute Resolution. This Agreement shall be governed by and construed in accordance with the Laws of the State
of New York, without regard to the conflict of laws principles thereof that would require the application of the Law of any other jurisdiction.
Any disputes as to matters arising out of or in connection with this Agreement will be subject to the procedures set forth in Section
13.5 of the Collaboration Agreement.

 

6.2             
Waiver. Neither party may waive or release any of its rights or interests in this Agreement except in writing. The failure
of either party to assert a right hereunder or to insist upon compliance with any term of this Agreement shall not constitute a waiver
of that right or excuse a similar subsequent failure to perform any such term or condition. No waiver by either party of any condition
or term in any one or more instances shall be construed as a continuing waiver of such condition or term or of another condition or term
except to the extent set forth in writing.

 

6.3             
Notices. All notices which are required or permitted hereunder shall be provided in accordance with Section 13.3 of the Collaboration
Agreement.

 

6.4             
Entire Agreement. This Agreement and the Collaboration Agreement, together with the schedules and exhibits thereto, set forth
all the covenants, promises, agreements, warranties, representations, conditions and understandings between the parties and supersede
and terminate all prior agreements and understanding between the parties. There are no covenants, promises, agreements, warranties, representations,
conditions or understandings, either oral or written, between the parties other than as set forth in this Agreement and the Collaboration
Agreement. No subsequent alteration, amendment, change or addition to this Agreement shall be binding upon the parties unless reduced
to writing and signed by the respective authorized officers of the parties.

 

6.5             
Headings; Pronouns; Section References. Headings and any table of contents used in this Agreement are for convenience only
and shall not in any way affect the construction of or be taken into consideration in interpreting this Agreement. Whenever the context
may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular
form of names and pronouns shall include the plural and vice-versa. References in this Agreement to a section or subsection shall be deemed
to refer to a section or subsection of this Agreement unless otherwise expressly stated.

 

6.6             
Severability. If, under applicable Laws, any provision of this Agreement is invalid or unenforceable, or otherwise directly
or indirectly affects the validity of any other material provision(s) of this Agreement in any jurisdiction (“Modified Clause”),
then, it is mutually agreed that this Agreement shall endure and that the Modified Clause shall be enforced in such jurisdiction to the
maximum extent permitted under applicable Laws in such jurisdiction; provided that the parties shall consult and use all reasonable
efforts to agree upon, and hereby consent to, any valid and enforceable modification of this Agreement as may be necessary to avoid any
unjust enrichment of either party and to match the intent of this Agreement as closely as possible, including the economic benefits and
rights contemplated in this Agreement.

 

6.7              Assignment.
Except for an assignment of this Agreement or any rights hereunder by the Investor to an Affiliate, neither this Agreement nor any
of the rights or obligations hereunder may be assigned by either the Investor or the Company without (a) the prior written
consent of the Company in the case of any assignment by the Investor or (b) the prior written consent of the Investor in the
case of an assignment by the Company.

 

    -16-

     

    

 

6.8             
Parties in Interest. All of the terms and provisions of this Agreement shall be binding upon, and shall inure to the benefit
of and be enforceable by the parties hereto and their respective successors, heirs, administrators and permitted assigns.

 

6.9             
Counterparts. This Agreement may be signed in counterparts, each and every one of which shall be deemed an original, notwithstanding
variations in format or file designation which may result from the electronic transmission, storage and printing of copies from separate
computers or printers. Facsimile signatures and signatures transmitted via PDF or DocuSign shall be treated as original signatures.

 

6.10         
Third Party Beneficiaries. None of the provisions of this Agreement shall be for the benefit of or enforceable by any Third
Party, including any creditor of any party hereto. No Third Party shall obtain any right under any provision of this Agreement or shall
by reason of any such provision make any claim in respect of any debt, liability or obligation (or otherwise) against any party hereto.

 

6.11         
No Strict Construction. This Agreement has been prepared jointly and will not be construed against either party.

 

6.12         
Remedies. The rights, powers and remedies of the parties under this Agreement are cumulative and not exclusive of any other
right, power or remedy which such parties may have under any other agreement or Law. No single or partial assertion or exercise of any
right, power or remedy of a party hereunder shall preclude any other or further assertion or exercise thereof.

 

6.13         
Expenses. Each party shall pay its own fees and expenses in connection with the preparation, negotiation, execution and delivery
of this Agreement.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    -17-

     

    

 

IN WITNESS WHEREOF, the parties intending to be
bound have caused this Securities Purchase Agreement to be executed by their duly authorized representatives as of the Effective Date.

 

	 	CENTURY THERAPEUTICS, INC.
	 	 
	 	By:	/s/ Osvaldo Flores, Ph.D.
	 	 	Name: Osvaldo Flores, Ph.D.
	 	 	Title: President and Chief Executive Officer

 

	 	BRISTOL-MYERS SQUIBB COMPANY
	 	 
	 	By:	/s/ Elizabeth Mily
	 	 	Name: Elizabeth Mily
	 	 	Title: Executive Vice President, Strategy and Business Development

 

[Signature Page to Securities
Purchase Agreement]EX-4.2

 Exhibit 4.2 

EXECUTION VERSION 

GENUINE PARTS COMPANY 

OFFICER’S CERTIFICATE PURSUANT TO 

SECTIONS 3.01 AND 3.03 OF THE INDENTURE IDENTIFIED BELOW 

The undersigned officer of Genuine Parts Company (the “Company”), acting pursuant to authorization contained in resolutions of the
Board of Directors of the Company (the “Board”) duly adopted on December 31, 2021 and in resolutions of the pricing committee established by the Board duly adopted on January 6, 2022 does hereby authorize, adopt and approve the
following terms for (a) a series of the Company’s debt securities designated as “1.750% Notes due 2025 (the “2025 Notes”) and (b) a series of the Company’s debt securities designated as “2.750% Notes due 2032
(the “2032 Notes” and, together with the 2025 Notes, the “Notes”), the Notes to be issued under an indenture, dated as of October 29, 2020 (the “Indenture”), between the Company and U.S. Bank National Association,
as trustee (the “Trustee”), which Notes have been registered for sale with the Securities and Exchange Commission pursuant to a Registration Statement on Form S-3 (No.
333-249625) under the Securities Act of 1933, as amended. Capitalized terms used but not defined herein shall have the meanings set forth in the Indenture. 

I. The 2025 Notes are entitled “1.750% Notes due 2025”. The 2032 Notes are entitled “2.750% Notes due 2032”. 

II. The 2025 Notes are limited in aggregate principal amount to U.S. $500,000,000 and the 2032 Notes are limited in aggregate principal amount
to U.S. $500,000,000, in each case, subject to (i) the Company’s right from time to time, without giving notice to or seeking the consent of the holders of a series of the Notes, to issue an unlimited amount of additional securities having
the same ranking and the same interest rate, maturity and other terms as such series of the Notes other than issue date, issue price and the payment of interest accruing prior to the issue date of the additional securities (such additional
securities having such similar terms, together with the applicable series of the Notes, constituting a single series of securities under the Indenture), provided that if such additional securities are not fungible with the then-outstanding Notes of
the applicable series for U.S. federal income tax purposes, the additional securities shall have a separate CUSIP number, and (ii) Notes of any series authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu
of, other Notes of such series pursuant to the provisions of the Indenture. 
 III. The 2025 Notes will mature on February 1, 2025 (the
“2025 Maturity”) and the 2032 Notes will mature on February 1, 2032 (the “2032 Maturity”), in each case, subject to the provisions of the Indenture and this Officer’s Certificate relating to acceleration and subject to
the provisions of the Indenture and this Officer’s Certificate relating to optional redemption. 
 A “Business Day” means
each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in New York City (or other Place of Payment specified pursuant to the Indenture) are authorized or obligated by law or executive order to close.

 IV. The 2025 Notes will bear interest at the rate per annum of 1.750%, from January 10,
2022, or from the most recent Interest Payment Date (as defined below) to which interest has been paid or provided for to, but excluding, the next Interest Payment Date or 2025 Maturity, as the case may be. The 2032 Notes will bear interest at the
rate per annum of 2.750%, from January 10, 2022, or from the most recent Interest Payment Date to which interest has been paid or provided for to, but excluding, the next Interest Payment Date or 2032 Maturity, as the case may be. Interest on
each series of Notes will be payable semiannually in arrears on February 1 and August 1 of each year (each, an “Interest Payment Date”), commencing on August 1, 2022, to the persons in whose names such Notes were registered
at the close of business on the immediately preceding January 15 and July 15, respectively (whether or not a business day) (each, a “Regular Record Date”). Interest on the Notes will be computed on the basis of a 360-day year comprised of twelve 30-day months. 
 V. Principal
and interest on the Notes shall be payable, and the Notes may be surrendered for registration of transfer or exchange, at the office or agency of the Company maintained for that purpose, pursuant to the Indenture, which shall initially be the
Corporate Trust Office of the Trustee located at, 1349 West Peachtree Street, N.W., Suite 1050, Atlanta, Georgia 30309, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and
private debt. 
 The Company, by or through the Trustee, may at its option pay interest by United States dollar check mailed to the address
of the Person entitled thereto as such address shall appear in the Security Register; provided, however, that payments in connection with Global Securities to The Depository Trust Company (“DTC”) will be made by wire transfer of
immediately available funds to the account of DTC or its nominee. 
 VI. The Notes are redeemable at the Company’s option, in whole or
in part, at any time and from time to time, prior to the applicable Par Call Date at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of: 

 

	 	•	 	 the (a) sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming the Notes matured on the applicable Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve
30-day months) at the applicable Treasury Rate plus 15 basis points for the 2025 Notes and 20 basis points for the 2032 Notes less (b) interest accrued to the date of redemption; and

  

	 	•	 	 100% of the principal amount of the Notes to be redeemed, 

plus, in each case, accrued and unpaid interest on such Notes to, but excluding, the redemption date. 

On or after the applicable Par Call Date, the Company may redeem the Notes of either series, in whole or in part, at any time and from time to
time, at a redemption price equal to 100% of the principal amount of the Notes of such series being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. 

Notwithstanding the foregoing, installments of interest on the Notes that are due and payable on Interest Payment Dates falling on or prior to
a redemption date will be payable on the relevant Interest Payment Date to the registered holders as of the close of business on the relevant record date. The redemption price will be calculated on the basis of a
360-day year consisting of twelve 30-day months. 

  
 2 

 Notice of any redemption will be mailed or electronically delivered (or otherwise
transmitted in accordance with the depositary’s procedures) at least 10 days but not more than 60 days before the redemption date to each registered holder of the Notes to be redeemed. Once notice of redemption is sent, the Notes called for
redemption will become due and payable on the redemption date and at the applicable redemption price, plus accrued and unpaid interest to the redemption date, subject to any conditions precedent specified in such notice. 

In the case of a partial redemption of a series of Notes, selection of the Notes of such series for redemption will be made pro rata, by lot
or by such other method as the Trustee in its sole discretion deems appropriate and fair unless otherwise required by law or applicable stock exchange or depositary requirements, including the applicable procedures of DTC. No Notes of a principal
amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new Note in a principal
amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another depositary), the redemption of the
Notes shall be done in accordance with the policies and procedures of the depositary. The Notes will not be entitled to the benefit of any mandatory redemption or sinking fund. 

On and after the redemption date, interest will cease to accrue on the Notes or any portion of the Notes called for redemption (unless the
Company defaults in the payment of the redemption price and accrued interest). On or before the redemption date, the Company will deposit with a paying agent or the Trustee money sufficient to pay the redemption price of and accrued interest on the
Notes to be redeemed on that date. 
 For purposes of this Clause VI: 

“Par Call Date” means February 1, 2023, in the case of the 2025 Notes and means November 1, 2031, in the case of the
2032 Notes (three months prior to maturity). 
 “Treasury Rate” means, with respect to any redemption date, the yield
determined by the Company in accordance with the following two paragraphs. 
 The Treasury Rate shall be determined by the Company after
4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third business day preceding the redemption date based upon the yield or
yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as “Selected Interest Rates (Daily)—H.15” (or
any successor designation or publication) (“H.15”) under the caption “U.S. government securities–Treasury constant maturities–Nominal” (or any successor caption or heading). In determining the Treasury Rate, the Company
shall select, as applicable: (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the applicable Par Call Date (the “Remaining Life”); or (2) if there is no such
Treasury constant maturity on H.15 exactly equal to 

  
 3 

 
the Remaining Life, the two yields – one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity
on H.15 immediately longer than the Remaining Life – and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or
(3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable
Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. 

If on the third business day preceding the redemption date H.15 is no longer published, the Company shall calculate the Treasury Rate based on
the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second business day preceding such redemption date of the United States Treasury security maturing on, or with a maturity that is
closest to, the applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the applicable Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant from
the applicable Par Call Date, one with a maturity date preceding the applicable Par Call Date and one with a maturity date following the applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date
preceding the applicable Par Call Date. If there are two or more United States Treasury securities maturing on the applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company
shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00
a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked
prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. 

VII. Change of Control Triggering Event 

Upon the occurrence of a Change of Control Triggering Event, unless the Company has defeased the Notes pursuant to Section 4.03 of the
Indenture or exercised its right to redeem the Notes as described in Clause VI hereof, each holder of Notes will have the right to require us to repurchase all or a portion of such holder’s Notes pursuant to the offer described below (the
“Change of Control Offer”), for cash, at a repurchase price equal to 101% of the aggregate principal amount thereof plus accrued and unpaid interest, if any, on the amount repurchased to, but not including, the date of repurchase, subject
to the rights of holders of Notes on the relevant record date to receive interest due on the relevant interest payment date. 
 Within 30
days following the date upon which the Change of Control Triggering Event occurred, or at the Company’s option, prior to any Change of Control but after the public announcement of the pending Change of Control, the Company is required to send,
by first class mail, a notice to each holder of Notes (or, in the case of global securities, electronically through the procedures of DTC), with a copy to the Trustee, which notice will govern the terms of the Change of Control Offer. Such notice
will state, among other things, the repurchase date, which 

  
 4 

 
must be no earlier than 30 days nor later than 60 days from the date such notice is sent (the “Change of Control Payment Date”). The notice, if sent prior to the date of consummation of
the Change of Control, will state that the Change of Control Offer is conditioned on the Change of Control being consummated on or prior to the Change of Control Payment Date. In addition, if such Change of Control Offer is subject to satisfaction
of such condition that the Change of Control Triggering Event occur on or prior to the applicable Change of Control Payment Date, such notice shall state that, in the Company’s discretion, the Change of Control Payment Date may be delayed until
such time (including more than 60 days after the date the notice of the Change of Control Offer was delivered) as such condition shall be satisfied or waived, or such Change of Control Offer may not occur and such notice may be rescinded in the
event that such condition shall not have been satisfied by the Change of Control Payment Date, or by the Change of Control Payment Date so delayed, or such notice may be rescinded at any time in the Company’s discretion if in its good faith
judgment such condition will not be satisfied. 
 Holders of Notes electing to have Notes repurchased pursuant to a Change of Control Offer
will be required to surrender their Notes, with the form entitled “Option of Holder to Elect Purchase” on the reverse of the Notes completed, to the paying agent at the address specified in the notice, or transfer their Notes to the paying
agent by book-entry transfer pursuant to the applicable procedures of the paying agent, prior to the close of business on the third business day prior to the Change of Control Payment Date. 

The Company shall not be required to make a Change of Control Offer if a third party makes such an offer in the manner, at the times and
otherwise in compliance with the requirements for such an offer made by us and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

For purposes of this Clause VII: 

“Change of Control” means the occurrence of any one of the following: 

(1) the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or
consolidation), in one or a series of related transactions, of all or substantially all of the assets of the Company and its subsidiaries taken as a whole to any Person (including any “person” (as that term is used in Section 13(d)(3)
of the Exchange Act)) other than the Company or one of its subsidiaries; 
 (2) the consummation of any transaction
(including, without limitation, any merger or consolidation) the result of which is that any Person (including any “person” or “group” (as those terms are used in Section 13(d)(3) of the Exchange Act)) becomes the
“beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the outstanding Voting Stock of
the Company or any other Voting Stock into which the Voting Stock of the Company is reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares; 

  
 5 

 (3) the Company consolidates with, or merges with or into, any Person, or
any Person consolidates with, or merges with or into, the Company, in any such event pursuant to a transaction in which any of the outstanding Voting Stock of the Company (or any other Voting Stock into which the Voting Stock of the Company is
reclassified, consolidated, exchanged or changed) is converted into or exchanged for cash, securities or other property, other than any such transaction where the shares of the Voting Stock of the Company (or any other Voting Stock into which the
Voting Stock of the Company is reclassified, consolidated, exchanged or changed) outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving Person immediately
after giving effect to such transaction; or 
 (4) the adoption of a plan relating to the liquidation or dissolution of the
Company. 
 Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control under clause (2) above if
(i) the Company becomes a direct or indirect wholly owned subsidiary of another corporate entity and (ii) the holders having ultimate beneficial ownership of the Voting Stock of such holding company immediately following that transaction
are substantially the same as the holders having beneficial ownership of the Company’s Voting Stock immediately prior to that transaction. The term “Person,” as used in this definition, has the meaning given thereto in
Section 13(d)(3) of the Exchange Act. 
 “Change of Control Triggering Event” means the occurrence of both a Change of
Control and a related Rating Event. 
 “Investment Grade” means a rating of Baa3 or better by Moody’s (or its
equivalent under any successor rating category of Moody’s) and a rating of BBB– or better by S&P (or its equivalent under any successor rating category of S&P) and the equivalent investment grade rating from any replacement Rating
Agency or Rating Agencies appointed by the Company. 
 “Moody’s” means Moody’s Investors Service, Inc. and its
successors. 
 “Person” means any individual, corporation, partnership, joint venture, association, joint- stock company,
trust, unincorporated organization, limited liability company or government or other entity. 
 “Rating Agency” means each
of Moody’s and S&P; provided that if either Moody’s or S&P ceases to provide rating services to issuers or investors, the Company may appoint a replacement for such Rating Agency. 

“Rating Event” means: 

(1) if the Notes are rated Investment Grade by each of the Rating Agencies on the first day of the Trigger Period, the Notes
cease to be rated Investment Grade by each of the Rating Agencies on any date during the Trigger Period, or 
 (2) if the
Notes are not rated Investment Grade by each of the Rating Agencies on the first day of the Trigger Period, the Notes are downgraded by at least one rating category (e.g., from BB+ to BB or Ba1 to Ba2) from the applicable rating of the Notes on the
first day of the Trigger Period by each of the Rating Agencies on any date during the Trigger Period. 

  
 6 

 “S&P” means S&P Global Ratings, a division of S&P Global, Inc.,
and its successors. 
 “Trigger Period” means the period commencing 60 days prior to the first public announcement by the
Company of any Change of Control (or pending Change of Control) and ending 60 days following consummation of such Change of Control (which Trigger Period will be extended following consummation of a Change of Control for so long as either of the
Rating Agencies has publicly announced that it is considering a possible ratings change). 
 “Voting Stock” of any
specified Person as of any date means the capital stock of such Person that is at the time entitled to vote generally in the election of the board of directors of such Person. 

VIII. Certain Covenants 

Limitation on liens 
 The
Company will not, and will not permit any of the Company’s subsidiaries to, create, incur, issue, assume or guarantee any debt for borrowed money secured by a Lien (other than Permitted Liens) upon any Property, or any shares of stock or
evidences of indebtedness issued by any of the Company’s subsidiaries and owned by the Company or by any other of the Company’s subsidiaries, owned on the date of issuance of the Notes, without making effective provision to secure all of
the notes, equally and ratably with any and all other debt secured thereby, so long as any of such other debt shall be so secured. 

Limitation on sale and leaseback transactions 

The Company will not, and will not permit any subsidiary to, after the date of the issue of the notes, enter into any arrangement with any
person providing for the leasing by the Company or any subsidiary of any Property that has been or is to be sold or transferred by the Company or such subsidiary to such person, with the intention of taking back a lease of such property or assets (a
“Sale and Leaseback Transaction”) unless either: 
 (i) within 12 months after the receipt of the proceeds of the
sale or transfer, the Company or any subsidiary apply an amount equal to the greater of the net proceeds of the sale or transfer or the fair value (as determined in good faith by the Company’s board of directors) of such Property at the time of
such sale or transfer to the prepayment or retirement (other than any mandatory prepayment or retirement) of Senior Funded Debt; or 

(ii) the Company or such subsidiary would be entitled, at the effective date of the sale or transfer, to incur debt secured by
a Lien on such Property in an amount at least equal to the Attributable Debt in respect of the Sale and Leaseback Transaction, without equally and ratably securing the notes pursuant to the covenant described under “—Limitation on
liens.” 

  
 7 

 The foregoing restriction in the paragraph above will not apply to any Sale and Leaseback
Transaction (i) for a term of not more than three years including renewals; (ii) between the Company and a subsidiary or between subsidiaries, provided that the lessor is the Company or a wholly owned subsidiary; or (iii) entered into
within 270 days after the later of the acquisition or completion of construction of the subject property or assets. 
 Merger,
consolidation or sale of assets 
 The Company shall not merge, consolidate or amalgamate with or into any other person or sell,
transfer, assign, lease, convey or otherwise dispose of all or substantially all of the Company’s property in any one transaction or series of related transactions unless: 

(1) the Company shall be the surviving person (the “Surviving Person”) or the Surviving Person (if other than the
Company) formed by such merger, consolidation or amalgamation or to which such sale, transfer, assignment, lease, conveyance or disposition is made shall be a person organized and existing under the laws of the U.S., any State thereof or the
District of Columbia, 
 (2) the Surviving Person (if other than the Company) expressly assumes, by supplemental indenture in
form reasonably satisfactory to the Trustee, executed and delivered to the Trustee by such Surviving Person, the due and punctual payment of the principal of, and premium, if any, and interest on, all the notes, according to their tenor, and the due
and punctual performance and observance of all the covenants and conditions of the Indenture to be performed by the Company, 

(3) immediately before and immediately after giving effect to such transaction or series of related transactions, no default or
event of default shall have occurred and be continuing, and 
 (4) the Company shall deliver, or cause to be delivered, to
the Trustee, an officer’s certificate and an opinion of counsel, each stating that such transaction and the supplemental indenture, if any, in respect thereto comply with this covenant and that all conditions precedent in the Indenture relating
to such transaction have been complied with. 
 For the purposes of this covenant, the sale, transfer, assignment, lease, conveyance or
other disposition of all the property of one or more subsidiaries of the Company, which property, if held by the Company instead of such subsidiaries, would constitute all or substantially all the property of the Company on a consolidated basis,
shall be deemed to be the transfer of all or substantially all the property of the Company. 
 For purposes of this Clause VIII: 

“Attributable Debt” in respect of a Sale and Leaseback Transaction means, at the time of determination, the present value
discounted at the rate of interest implicit in the terms of the lease (as determined in good faith by the Company) of the obligations of the lessee under such lease for net rental payments (including a reduction for any amounts required to be paid
on account of maintenance and repairs, insurance, taxes, assessments, water rates and similar charges) during the remaining term of the lease (including any period for which such lease has been extended). 

  
 8 

 “Consolidated Net Tangible Assets” means the aggregate amount of the
Company’s assets (including right of use assets and less applicable reserves and other properly deductible items) and the Company’s consolidated subsidiaries’ assets after deducting therefrom (a) all current liabilities
(excluding the sum of any debt for money borrowed having a maturity of less than twelve months from the date of the Company’s most recent consolidated balance sheet but which by its terms is renewable or extendable beyond twelve months from
such date at the option of the borrower and, without duplication, any current installments thereof payable within such twelve month period) and (b) all goodwill, trade names, patents, unamortized debt discount and expense and other like
intangibles, all as set forth on the Company’s most recent consolidated balance sheet and computed in accordance with United States generally accepted accounting principles (“GAAP”). 

“Funded Debt” means debt which matures more than one year from the date of creation, or which is extendable or renewable at
the sole option of the obligor so that it may become payable more than one year from such date or which is classified, in accordance with GAAP, as long-term debt on the consolidated balance sheet for the most-recently ended fiscal quarter (or if
incurred subsequent to the date of such balance sheet, would have been so classified) of the person for which the determination is being made. Funded Debt does not include (1) obligations created pursuant to leases, (2) any debt or portion
thereof maturing by its terms within one year from the time of any computation of the amount of outstanding Funded Debt unless such debt shall be extendable or renewable at the sole option of the obligor in such manner that it may become payable
more than one year from such time, or (3) any debt for which money in the amount necessary for the payment or redemption of such debt is deposited in trust either at or before the maturity date thereof. 

“Lien” means, with respect to any Property, shares of stock or evidences of indebtedness, any mortgage or deed of trust,
pledge, hypothecation, security interest, lien, encumbrance or other security arrangement of any kind or nature on or with respect to such Property, shares of stock or evidences of indebtedness. 

“Permitted Liens” means: 

(1) Liens (other than Liens created or imposed under the Employee Retirement Income Security Act of 1974, as amended
(“ERISA”)), for taxes, assessments or governmental charges or levies not yet subject to penalties for non-timely payment or Liens for taxes being contested in good faith by appropriate proceedings
for which adequate reserves determined in accordance with GAAP have been established (and as to which the property or assets subject to any such Lien is not yet subject to foreclosure, sale or loss on account thereof); 

(2) statutory Liens of landlords and Liens of mechanics, materialmen, repairmen, warehousemen, carriers and suppliers and other
Liens imposed by law or pursuant to customary reservations or retentions of title arising in the ordinary course of business, provided that any such Liens which are material secure only amounts not yet due and payable or, if due and payable, are
unfiled and no other action has been taken to enforce the same or are being contested in good faith by appropriate proceedings for which adequate reserves determined in accordance with GAAP have been established (and as to which the property or
assets subject to any such Lien is not yet subject to foreclosure, sale or loss on account thereof); 

  
 9 

 (3) Liens (other than Liens created or imposed under ERISA) incurred or
deposits made by the Company and the Company’s subsidiaries in the ordinary course of business in connection with workers’ compensation, unemployment insurance and other types of social security, laws or regulations, or to secure the
performance of tenders, statutory obligations, surety and appeal bonds, bids, leases, trade or government contracts, surety, indemnification, appeal, performance and
return-of- money bonds, letters of credit, bankers acceptances and other similar obligations (exclusive of obligations for the payment of borrowed money), or as security
for customs or import duties and related amounts; 
 (4) Liens in connection with attachments or judgments (including
judgment or appeal bonds), provided that the judgments secured shall, within 30 days after the entry thereof, have been discharged or execution thereof stayed pending appeal, or shall have been discharged within 30 days after the expiration of any
such stay; 
 (5) Liens securing indebtedness (including any Liens, interest or title of a lessor under any capital leases)
incurred or assumed to finance the purchase price or cost of development or construction of property or assets (or additions, repairs, alterations or improvements thereto), provided that the commitment of the creditor to extend the credit secured by
any such Liens shall have been obtained within twelve months of the later of (a) acquisition or completion of construction or development (or addition, repair, alteration or improvement) and (b) full operation thereof; 

(6) Liens securing industrial revenue bonds, pollution control bonds or similar types of
tax-exempt bonds; 
 (7) Liens arising from deposits with, or the giving of any form
of security to, any governmental agency required as a condition to the transaction of business or exercise of any privilege, franchise or license, or Liens encumbering deposits made in the ordinary course of business to secure nondelinquent
obligations arising from statutory, regulatory, contractual or warranty requirements of the Company or its subsidiaries; 

(8) encumbrances, covenants, conditions, restrictions, easements, reservations and rights of way or zoning, building code or
other restrictions, (including defects or irregularities in title and similar encumbrances) as to the use of real property, or Liens incidental to conduct of the business or to the ownership of the Company’s or the Company’s
subsidiaries’ properties not securing debt that do not in the aggregate materially impair the use of said properties in the operation of the Company’s business, including the Company’s subsidiaries, taken as a whole; 

(9) leases, licenses, subleases or sublicenses granted to others not interfering in any material respect with the
Company’s business, including the Company’s subsidiaries, taken as a whole; 

  
 10 

 (10) Liens on property or assets or shares of stock or evidences of
indebtedness for borrowed money at the time such property or assets are acquired by the Company or any of the Company’s subsidiaries; 

(11) Liens on property or assets of any person, or any shares of stock or evidences of indebtedness for borrowed money, at the
time such person becomes one of the Company’s subsidiaries; 
 (12) Liens on receivables from customers sold to third
parties pursuant to credit arrangements in the ordinary course of business or consistent with past practice; 
 (13) Liens
existing on the date of this prospectus supplement or any extensions, amendments, renewals, refinancings, replacements or other modifications thereto; 

(14) Liens on any property or assets created, assumed or otherwise brought into existence in contemplation of the sale or other
disposition of the underlying property or assets, whether directly or indirectly, by way of share disposition or otherwise; 

(15) Liens securing debt of a subsidiary owed to the Company or to another one of the Company’s subsidiaries; 

(16) Liens in favor of the United States of America or any State thereof, or any department, agency or instrumentality or
political subdivision thereof, to secure partial, progress, advance or other payments; 
 (17) Liens to secure debt of joint
ventures in which the Company or any of the Company’s subsidiaries have an interest, to the extent such Liens are on property or assets of, or equity interests in, such joint ventures; 

(18) Liens arising solely by virtue of any statutory or common law provisions relating to banker’s Liens, rights of set-off or similar rights and remedies as to deposit accounts or other funds maintained with a depositary institution; 

(19) Liens arising from financing statement filings regarding operating leases; 

(20) Liens in favor of customs and revenue authorities to secure custom duties in connection with the importation of goods;

 (21) Liens securing the financing of insurance premiums payable on insurance policies; provided, that such Liens shall
only encumber unearned premiums with respect to such insurance, interests in any state guarantee fund relating to such insurance and subject and subordinate to the rights and interests of any loss payee, loss payments which shall reduce such
unearned premiums; 
 (22) Liens securing cash management obligations (that do not constitute indebtedness), or arising out
of conditional sale, title retention, consignment or similar arrangements for sale of goods and contractual rights of set-off relating to purchase orders and other similar arrangements, in each case in the
ordinary course of business or consistent with past practice; 

  
 11 

 (23) Liens on any property or assets of the Company’s foreign
subsidiaries securing debt of such subsidiaries (but not debt of the Company or any of the Company’s domestic subsidiaries); 

(24) Liens securing debt in an aggregate principal amount at any time outstanding not exceeding $1,000.0 million in
respect of any arrangement under which the Company or any of the Company’s subsidiaries transfer, once or on a revolving basis, without recourse (except for indemnities and representations customary for securitization transactions and except
for the retention of risk in an amount and form required by applicable laws and regulations or as is customary for a similar type of transaction) involving one or more “true sale” transactions, accounts receivable or interests therein and
related assets customarily transferred in connection with securitization transactions (i) to a trust, partnership, corporation, limited liability company or other entity, which transfer is funded in whole or in part, directly or indirectly, by
the incurrence or issuance by the transferee or successor transferee of indebtedness or other securities that are to receive payments from, or that represent interests in, the cash flow derived from such accounts receivable or interests therein, or
(ii) directly to one or more investors or other purchasers; 
 (25) other Liens on the Company’s property or assets
and the property or assets of the Company’s subsidiaries securing debt in an aggregate principal amount (together with the aggregate amount of all Attributable Debt in respect of Sale and Leaseback Transactions entered into in reliance on this
clause) not to exceed, as of any date of incurrence of such secured debt pursuant to this clause and after giving effect to such incurrence and the application of the proceeds therefrom, the greater of (a) $700 million and (b) 15% of the
Company’s Consolidated Net Tangible Assets; and 
 (26) any extensions, amendments, renewals, refinancings, replacements
or other modifications thereto (or successive extensions, amendments, renewals, refinancings, replacements or other modifications thereto), as a whole or in part, of any Lien referred to in subparagraphs (1) through (25) above or the
indebtedness secured thereby; provided that the Lien so extended, amended, renewed, refinanced, replaced or otherwise modified does not extend to any additional property or assets. 

“Property” means any building, structure or other facility, together with the land upon which it is erected and fixtures
comprising a part thereof, used primarily for selling automotive parts and accessories or the warehousing or distributing of such products, owned or leased by the Company or any one of the Company’s Significant Subsidiaries. 

“Senior Funded Debt” means all Funded Debt of the Company’s or the Company’s subsidiaries (except Funded Debt, the
payment of which is subordinated to the payment of the notes). 
 “Significant Subsidiaries” means any of the
Company’s subsidiaries that is a “significant subsidiary” as defined in Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act. 

  
 12 

 IX. The Notes shall not be entitled to the benefit of any mandatory redemption or sinking
fund. 
 X. The Notes shall be issued only in minimum denominations of U.S. $2,000, and any integral multiple of U.S. $1,000 in excess
thereof. 
 XI. The Trustee, Paying Agent and Security Registrar for the Notes shall initially be U.S. Bank National Association. 

XII. Upon issuance, the Notes will be represented by one or more global Securities representing all of the aggregate principal amount of such
Notes and will be registered in the name of the nominee of DTC, which will act as depositary. DTC, or any successor depositary for the Notes permitted by the terms of the Indenture, this Officer’s Certificate and the Notes, is hereinafter
referred to as the “Depositary.” Except as set forth in the Indenture, owners of beneficial interests in the Notes will not be entitled to have Notes registered in their names, will not receive or be entitled to receive Notes in definitive
form and will not be considered Holders of Notes under the Indenture. 
 Notwithstanding any other provisions of the Indenture, this
Officer’s Certificate or the Notes, unless and until exchanged in whole or in part for the individual Securities represented thereby, the global Security or Securities representing all or a portion of the Notes of the applicable series may not
be transferred except, as provided in Section 3.05 of the Indenture, by the Depositary to another nominee of the Depositary for the Notes, or by a nominee of such Depositary to such Depositary or another nominee of such Depositary, or by such
Depositary or any such nominee to a successor Depositary or nominee of such successor Depositary. 
 XIII. The Notes shall be defeasible
pursuant to Section 4.03 of the Indenture. 
 XIV. The issue price to public of the 2025 Notes shall be 99.721% of the principal amount
of the 2025 Notes and 98.810% of the principal amount of the 2032 Notes. 
 XV. The underwriters’ commission or discount as a
percentage of the principal amount of the 2025 Notes shall be 0.350% of the principal amount of the Notes and 0.650% of the principal amount of the 2032 Notes. 

Furthermore, the Company hereby approves the form of and authorize the execution and delivery of the 2025 Notes and 2032 Notes substantially
in the forms attached hereto as Exhibit A and Exhibit B, respectively. 
 XVI. This Officer’s Certificate may be executed in any number
of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument. The exchange of copies of this Officer’s Certificate and of signature pages by
facsimile, PDF or other electronic transmission shall constitute effective execution and delivery of this Officer’s Certificate as to the parties hereto and may be used in lieu of the original Officer’s Certificate for all purposes.
Signatures of the parties hereto transmitted by facsimile, PDF or other electronic transmission shall be deemed to be their original signatures for all purposes. All notices, approvals, consents, requests and any communications hereunder must be in
writing (provided that any communication sent to Trustee hereunder must be in the form of 

  
 13 

 
a document that is signed manually or by way of a digital signature provided by DocuSign (or such other digital signature provider as specified in writing to Trustee by the authorized
representative), in English. The Company agrees to assume all risks arising out of the use of using digital signatures and electronic methods to submit communications to Trustee, including without limitation the risk of Trustee acting on
unauthorized instructions, and the risk of interception and misuse by third parties. 

  
 14 

 IN WITNESS WHEREOF, the undersigned has executed this Officer’s Certificate on behalf
of the Company as of this 10th day of January, 2022. 
  

			
		
	By:	 	/s/ Charles A. Chesnutt
		 	Name: Charles A. Chesnutt
		 	Title: Senior Vice President and Treasurer

 [Form of 1.750% Note due 2025] 

[Face of Security] 
 UNLESS
THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SECURITY ISSUED IS REGISTERED
IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY
TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF DTC OR A
NOMINEE THEREOF. THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN DTC OR SUCH NOMINEE, EXCEPT IN THE
LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE. 
 GENUINE PARTS COMPANY 

 

			
	No. [    ]	  	U.S. $[    ]
		  	CUSIP / ISIN: [        ] / [    ]

 GENUINE PARTS COMPANY, a corporation duly organized and existing under the laws of the State of Georgia
(herein called the “Company”, which term includes any successor Person under the Indenture referred to on the reverse hereof), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of
[    ] UNITED STATES DOLLARS on February 1, 2025 and to pay interest thereon from January 10, 2022 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semiannually in
arrears on February 1 and August 1 in each year, commencing on August 1, 2022 at the rate of 1.750% per annum, computed on the basis of a 360-day year comprised of twelve 30-day months, until the principal hereof is paid or made available for payment. The interest so payable, and timely paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be
paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be the January 15 or July 15 (whether or not a Business
Date), as the case may be, next preceding such Interest Payment Date. Except as otherwise provided in the Indenture, any such interest not so timely paid or duly provided for will forthwith cease to be payable to the Holder on such Regular Record
Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Company,
notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on
which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

 Payment of the principal of (and premium, if any) and any such interest on this Security
will be made at the office or agency of the Company maintained for that purpose, pursuant to the Indenture, which shall initially be the Corporate Trust Office of the Trustee located at 1349 West Peachtree Street, N.W., Suite 1050, Atlanta, Georgia
30309, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debt; provided, however, (a) in the case of Securities in global form registered in the name of
or held by DTC or its nominee, payment of the principal of (and premium, if any) and interest will be made in immediately available funds to DTC or its nominee, as the case may be, as the registered holder of such Global Security, and (b) in
the case of other Securities, at the option of the Company payment of the principal of (and premium, if any) and interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security
Register. 
 Reference is hereby made to the further provisions of this Security set forth on the reverse side hereof, which further
provisions shall for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has
been executed by the Trustee referred to on the reverse hereof, directly or through an Authenticating Agent, by manual signature of an authorized signatory, this Security shall not be entitled to any benefit under the Indenture or be valid or
obligatory for any purpose. 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

Dated: January [    ], 2022 
  

			
	GENUINE PARTS COMPANY
		
	By:	 	 
		 	Name:
		 	Title:

 CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated herein issued under the Indenture described herein. 

Dated: January [    ], 2022 
  

			
	 U.S. BANK NATIONAL ASSOCIATION,

    as Trustee

		
	By:	 	 
		 	Title: Authorized Signatory

 [Reverse of Security] 

This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to be
issued in one or more series under an Indenture, dated as of October 29, 2020 (the “Base Indenture”), between the Company and U.S. Bank National Association, as Trustee (herein called the “Trustee”, which term includes any
successor trustee under the Indenture), as supplemented by the Officer’s Certificate, dated January 10, 2022 (the “Officer’s Certificate” and, together with the Base Indenture, the “Indenture”), to which Indenture
and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon
which the Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, limited in aggregate principal amount to U.S. $500,000,000, subject to the Company’s right from time to
time, without giving notice to or seeking the consent of the holders of the Securities, to issue an unlimited amount of additional securities in one or more series having the same ranking and the same interest rate, maturity and other terms as the
Securities other than issue date, issue price and the payment of interest accruing prior to the issue date of the additional securities (such additional securities having such similar terms, together with the Securities of this series, constituting
a single issue of Securities under the Indenture), provided that if such additional securities are not fungible with the then-outstanding Securities of this series for U.S. federal income tax purposes, the additional securities shall have a separate
CUSIP number. The Securities of this series are issuable as Securities only in registered form, without coupons in denominations of U.S. $2,000 or any integral multiple of U.S. $1,000 in excess thereof. As provided in the Indenture and subject to
certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of any authorized denominations, as requested by the Holder surrendering the same,
upon surrender of the Security or Securities to be exchanged at any office or agency described below where Securities of this series may be presented for registration of transfer. 

This Security is subject to the covenants contained in the Indenture and certain additional covenants contained in the Officers’
Certificate. 
 Any or all of the Securities are redeemable at the Company’s option, in whole or in part, at any time and from time to
time, prior to February 1, 2023 (the “2025 Notes Par Call Date”) at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of: 

 

	 	•	 	 the (a) sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming the Notes matured on the 2025 Notes Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve
30-day months) at the applicable Treasury Rate plus 15 basis points for the 2025 Notes less (b) interest accrued to the date of redemption; and 

 

	 	•	 	 100% of the principal amount of the Notes to be redeemed, 

plus, in each case, accrued and unpaid interest on such Notes to, but excluding, the redemption date. 

 The redemption price for any Securities to be redeemed on or after the 2025 Notes Par Call
Date will be equal to 100% of the principal amount of the Securities being redeemed on such redemption date, plus accrued and unpaid interest on such Securities, but excluding, the redemption date. 

Notwithstanding the foregoing, installments of interest on the Notes that are due and payable on Interest Payment Dates falling on or prior to
a redemption date will be payable on the relevant Interest Payment Date to the registered holders as of the close of business on the relevant Regular Record Date. The redemption price will be calculated on the basis of a 360-day year consisting of twelve 30-day months. 
 Partial
redemption must be made in an amount not less than U.S. $2,000 or any integral multiple of U.S. $1,000 in excess thereof. 
 Notice of
redemption will be sent to Holders of Securities, at least 10 days but not more than 60 days to the date fixed for redemption, all as provided in the Indenture. 

In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed
portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof. 
 “Treasury Rate” means, with
respect to any redemption date, the yield determined by the Company in accordance with the following two paragraphs. 
 The Treasury Rate
shall be determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third business day preceding the
redemption date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as “Selected
Interest Rates (Daily)—H.15” (or any successor designation or publication) (“H.15”) under the caption “U.S. government securities–Treasury constant maturities–Nominal” (or any successor caption or heading). In
determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the 2025 Notes Par Call Date (the “Remaining
Life”); or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields – one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield
corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life – and shall interpolate to the 2025 Notes Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding
the result to three decimal places; or (3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For
purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the
redemption date. 

 If on the third business day preceding the redemption date H.15 is no longer published, the
Company shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second business day preceding such redemption date of the United States Treasury
security maturing on, or with a maturity that is closest to, the 2025 Notes Par Call Date, as applicable. If there is no United States Treasury security maturing on the 2025 Notes Par Call Date but there are two or more United States Treasury
securities with a maturity date equally distant from the 2025 Notes Par Call Date, one with a maturity date preceding the 2025 Notes Par Call Date and one with a maturity date following the 2025 Notes Par Call Date, the Company shall select the
United States Treasury security with a maturity date preceding the 2025 Notes Par Call Date. If there are two or more United States Treasury securities maturing on the 2025 Notes Par Call Date or two or more United States Treasury securities meeting
the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for
such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be
based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. 

Subject to certain conditions set forth in the Indenture, the Company at any time may discharge or defease some of or all of its obligations
under this Security and the Indenture in accordance with Section 4.03 of the Indenture. 
 If an Event of Default with respect to
Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations
of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the
time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding (with each series voting as a
separate class in certain cases specified in the Indenture, or with all series voting as one class, in certain other cases specified in the Indenture), on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of
this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notification of such consent or waiver is made upon this Security. 

As set forth in, and subject to, the provisions of the Indenture, no Holder of any Security of this series will have any right to institute
any proceeding with respect to the Indenture or for any remedy thereunder, unless such Holder shall have previously given to the Trustee written notice at the Corporate Trust Office of a continuing Event of Default with respect to this series,

 
the Holders of not less than 25% in principal amount of the Outstanding Securities of this series and all other affected series shall have made written request to the Trustee to institute such
proceeding as trustee (and offered security or indemnity satisfactory to the Trustee), and the Trustee shall not have received from the Holders of a majority in principal amount of the Outstanding Securities of all affected series a direction
inconsistent with such request and shall have failed to institute such proceedings within 60 days; provided, however, that such limitations do not apply to a suit instituted by the Holder hereof for the enforcement of payment of the principal of
(and premium, if any) or any interest on this Security on or after the respective due dates expressed herein. 
 No reference herein to the
Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of (and premium, if any) and any interest on this Security at the times,
places and rate, and in the coin or currency, herein prescribed. 
 As provided in the Indenture and subject to certain limitations therein
set forth, the transfer of this Security is registrable in the Security Register, upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of (and premium, if any) and any
interest on such Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in
writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. The Company and the Trustee
shall be entitled to request an opinion of counsel providing that the transfer complies with applicable securities laws. 
 No service
charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security is overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

Notwithstanding anything in the Indenture or in the terms of this Security to the contrary, the exchange of this Security for a Security will
be subject to satisfaction of the provisions of the United States tax laws in effect at the time of the exchange. Neither the Company nor the Trustee nor any agent of the Company or the Trustee shall be required to exchange this Security for a
Security if (a) as a result thereof and in the Company’s judgment, the Company would incur adverse consequences under then applicable United States Federal income tax laws and (b) in the case of the Trustee or any agent of the Company
or the Trustee, the Company shall have delivered to such Person an Officer’s Certificate and an Opinion of Counsel as to the matters set forth in clause (a) above. 

The Indenture and the Securities shall be governed by and construed in accordance with the laws of the State of New York. 

 All terms used in this Security which are defined in the Indenture shall have the meanings
assigned to them in the Indenture. 

 [Form of 2.750% Note due 2032] 

[Face of Security] 

UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”),
TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SECURITY ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE
TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE & CO., HAS AN INTEREST HEREIN. 
 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED
TO AND IS REGISTERED IN THE NAME OF DTC OR A NOMINEE THEREOF. THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER
THAN DTC OR SUCH NOMINEE, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE. 
 GENUINE PARTS COMPANY 

 

			
	 No. [    ]
	  	U.S. $[        ]
		  	CUSIP / ISIN: [        ] / [    ]

 GENUINE PARTS COMPANY, a corporation duly organized and existing under the laws of the State of Georgia
(herein called the “Company”, which term includes any successor Person under the Indenture referred to on the reverse hereof), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of
[    ] UNITED STATES DOLLARS on February 1, 2032 and to pay interest thereon from January 10, 2022 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semiannually in
arrears on February 1 and August 1 in each year, commencing on August 1, 2022 at the rate of 2.750% per annum, computed on the basis of a 360-day year comprised of twelve 30- day months, until the principal hereof is paid or made available for payment. The interest so payable, and timely paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be
paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be the January 15 or July 15 (whether or not a Business
Date), as the case may be, next preceding such Interest Payment Date. Except as otherwise provided in the Indenture, any such interest not so timely paid or duly provided for will forthwith cease to be payable to the Holder on such Regular Record
Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Company,
notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on
which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

 Payment of the principal of (and premium, if any) and any such interest on this Security
will be made at the office or agency of the Company maintained for that purpose, pursuant to the Indenture, which shall initially be the Corporate Trust Office of the Trustee located at 1349 West Peachtree Street, N.W., Suite 1050, Atlanta, Georgia
30309, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debt; provided, however, (a) in the case of Securities in global form registered in the name of
or held by DTC or its nominee, payment of the principal of (and premium, if any) and interest will be made in immediately available funds to DTC or its nominee, as the case may be, as the registered holder of such Global Security, and (b) in
the case of other Securities, at the option of the Company payment of the principal of (and premium, if any) and interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security
Register. 
 Reference is hereby made to the further provisions of this Security set forth on the reverse side hereof, which further
provisions shall for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has
been executed by the Trustee referred to on the reverse hereof, directly or through an Authenticating Agent, by manual signature of an authorized signatory, this Security shall not be entitled to any benefit under the Indenture or be valid or
obligatory for any purpose. 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

 

							
	 Dated: January [     ], 2022
	 		 	
			
		 		 	 GENUINE PARTS COMPANY

				
		 		 	 By:
	 	 
		 		 		 	Name:
		 		 		 	Title:

 CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated herein issued under the Indenture described herein. 

 

							
	 Dated: January [     ], 2022
	 		 	
			
		 		 	 U.S. BANK NATIONAL ASSOCIATION,

    as Trustee

				
		 		 	 By:
	 	 
		 		 		 	 Title: Authorized Signatory

 [Reverse of Security] 

This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to be
issued in one or more series under an Indenture, dated as of October 29, 2020 (the “Base Indenture”), between the Company and U.S. Bank National Association, as Trustee (herein called the “Trustee”, which term includes any
successor trustee under the Indenture), as supplemented by the Officer’s Certificate, dated January 10, 2022 (the “Officer’s Certificate” and, together with the Base Indenture, the “Indenture”), to which Indenture
and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon
which the Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, limited in aggregate principal amount to U.S. $500,000,000, subject to the Company’s right from time to
time, without giving notice to or seeking the consent of the holders of the Securities, to issue an unlimited amount of additional securities in one or more series having the same ranking and the same interest rate, maturity and other terms as the
Securities other than issue date, issue price and the payment of interest accruing prior to the issue date of the additional securities (such additional securities having such similar terms, together with the Securities of this series, constituting
a single issue of Securities under the Indenture), provided that if such additional securities are not fungible with the then-outstanding Securities of this series for U.S. federal income tax purposes, the additional securities shall have a separate
CUSIP number. The Securities of this series are issuable as Securities only in registered form, without coupons in denominations of U.S. $2,000 or any integral multiple of U.S. $1,000 in excess thereof. As provided in the Indenture and subject to
certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of any authorized denominations, as requested by the Holder surrendering the same,
upon surrender of the Security or Securities to be exchanged at any office or agency described below where Securities of this series may be presented for registration of transfer. 

This Security is subject to the covenants contained in the Indenture and certain additional covenants contained in the Officers’
Certificate. 
 Any or all of the Securities are redeemable at the Company’s option, in whole or in part, at any time and from time to
time, prior to November 1, 2031 (the “2032 Notes Par Call Date”) at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of: 

 

	 	•	 	 the (a) sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming the Notes matured on the 2032 Notes Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve
30-day months) at the applicable Treasury Rate plus 20 basis points for the 2032 Notes less (b) interest accrued to the date of redemption; and 

 

	 	•	 	 100% of the principal amount of the Notes to be redeemed, 

plus, in each case, accrued and unpaid interest on such Notes to, but excluding, the redemption date. 

 The redemption price for any Securities to be redeemed on or after the 2032 Notes Par Call
Date will be equal to 100% of the principal amount of the Securities being redeemed on such redemption date, plus accrued and unpaid interest on such Securities, but excluding, the redemption date. 

Notwithstanding the foregoing, installments of interest on the Notes that are due and payable on Interest Payment Dates falling on or prior to
a redemption date will be payable on the relevant Interest Payment Date to the registered holders as of the close of business on the relevant Regular Record Date. The redemption price will be calculated on the basis of a 360-day year consisting of twelve 30-day months. 
 Partial
redemption must be made in an amount not less than U.S. $2,000 or any integral multiple of U.S. $1,000 in excess thereof. 
 Notice of
redemption will be sent to Holders of Securities, at least 10 days but not more than 60 days to the date fixed for redemption, all as provided in the Indenture. 

In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed
portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof. 
 “Treasury Rate” means, with
respect to any redemption date, the yield determined by the Company in accordance with the following two paragraphs. 
 The Treasury Rate
shall be determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third business day preceding the
redemption date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as “Selected
Interest Rates (Daily)—H.15” (or any successor designation or publication) (“H.15”) under the caption “U.S. government securities–Treasury constant maturities–Nominal” (or any successor caption or heading). In
determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the 2032 Notes Par Call Date (the “Remaining
Life”); or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields – one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield
corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life – and shall interpolate to the 2032 Notes Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding
the result to three decimal places; or (3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For
purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the
redemption date. 

 If on the third business day preceding the redemption date H.15 is no longer published, the
Company shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second business day preceding such redemption date of the United States Treasury
security maturing on, or with a maturity that is closest to, the 2032 Notes Par Call Date, as applicable. If there is no United States Treasury security maturing on the 2032 Notes Par Call Date but there are two or more United States Treasury
securities with a maturity date equally distant from the 2032 Notes Par Call Date, one with a maturity date preceding the 2032 Notes Par Call Date and one with a maturity date following the 2032 Notes Par Call Date, the Company shall select the
United States Treasury security with a maturity date preceding the 2032 Notes Par Call Date. If there are two or more United States Treasury securities maturing on the 2032 Notes Par Call Date or two or more United States Treasury securities meeting
the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for
such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be
based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. 

Subject to certain conditions set forth in the Indenture, the Company at any time may discharge or defease some of or all of its obligations
under this Security and the Indenture in accordance with Section 4.03 of the Indenture. 
 If an Event of Default with respect to
Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations
of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the
time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding (with each series voting as a
separate class in certain cases specified in the Indenture, or with all series voting as one class, in certain other cases specified in the Indenture), on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of
this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notification of such consent or waiver is made upon this Security. 

As set forth in, and subject to, the provisions of the Indenture, no Holder of any Security of this series will have any right to institute
any proceeding with respect to the Indenture or for any remedy thereunder, unless such Holder shall have previously given to the Trustee written notice at the Corporate Trust Office of a continuing Event of Default with respect to this series,

 
the Holders of not less than 25% in principal amount of the Outstanding Securities of this series and all other affected series shall have made written request to the Trustee to institute such
proceeding as trustee (and offered security or indemnity satisfactory to the Trustee), and the Trustee shall not have received from the Holders of a majority in principal amount of the Outstanding Securities of all affected series a direction
inconsistent with such request and shall have failed to institute such proceedings within 60 days; provided, however, that such limitations do not apply to a suit instituted by the Holder hereof for the enforcement of payment of the principal of
(and premium, if any) or any interest on this Security on or after the respective due dates expressed herein. 
 No reference herein to the
Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of (and premium, if any) and any interest on this Security at the times,
places and rate, and in the coin or currency, herein prescribed. 
 As provided in the Indenture and subject to certain limitations therein
set forth, the transfer of this Security is registrable in the Security Register, upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of (and premium, if any) and any
interest on such Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in
writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. The Company and the Trustee
shall be entitled to request an opinion of counsel providing that the transfer complies with applicable securities laws. 
 No service
charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security is overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

Notwithstanding anything in the Indenture or in the terms of this Security to the contrary, the exchange of this Security for a Security will
be subject to satisfaction of the provisions of the United States tax laws in effect at the time of the exchange. Neither the Company nor the Trustee nor any agent of the Company or the Trustee shall be required to exchange this Security for a
Security if (a) as a result thereof and in the Company’s judgment, the Company would incur adverse consequences under then applicable United States Federal income tax laws and (b) in the case of the Trustee or any agent of the Company
or the Trustee, the Company shall have delivered to such Person an Officer’s Certificate and an Opinion of Counsel as to the matters set forth in clause (a) above. 

The Indenture and the Securities shall be governed by and construed in accordance with the laws of the State of New York. 

 All terms used in this Security which are defined in the Indenture shall have the meanings
assigned to them in the Indenture.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]